Exelixis, Inc. at its Annual Meeting of Shareholders of 2023, approved election to the Board of Directors of Farallon Capital Management, L.L.C. director candidate: Dave Johnson.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.24 USD | -1.58% | -3.78% | -15.69% |
05-20 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
05-14 | Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.69% | 5.99B | |
+9.86% | 118B | |
+10.06% | 106B | |
-11.69% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.51% | 15.97B | |
+6.50% | 14.03B | |
+16.42% | 11.67B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis, Inc. Elects Dave Johnson to its Board of Directors